This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Navidea Biopharmaceuticals, Inc., a precision medicine company, focuses on the development and commercialization of precision diagnostics, therapeutics, and radiopharmaceutical agents.View NAVB key stats
Navidea Biopharmaceuticals Inc - NAVB - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Navidea Biopharmaceuticals Inc as a
Sell with a ratings score of D-.
Report Snippet: We rate NAVIDEA BIOPHARMACEUTICALS (NAVB) a SELL. This is driven by multiple weaknesses, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The area that we feel has been the company's primary weakness has been its unimpressive growth in net income.